| Deler fremragende | 495,092 shares |
| Insideraktier | 6.134.937 shares |
| Total Insiders | 22 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
LadRx Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Earl W Brien Director - [D] | 590.247 | 590.247 | |
| John Y Caloz Chief Financial Officer - [O] | 31.792 | 5.299 | |
| Joel K Caldwell Director - [D] | 335.373 | 335.373 | |
| Anita J Chawla | 180.000 | ||
| Chawla Shanta M.D. Senior VP-Drug Development - [O] | 4.200 | 700 | |
| Cheryl Cohen | 180.000 | ||
| Eric Curtis | 0 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Louis Ignarro Director - [D] | 600.785 | 600.785 | |
| Steven A Kriegsman Chief Executive Officer, Director - [D] [O] | 3.668.038 | 3.668.038 | |
| Felix Kratz | 25.000 | ||
| Daniel J Levitt EVP and Chief Medical Officer - [O] | 161.036 | 26.839 | |
| Max Link Director - [D] | 260.305 | 43.384 | |
| Ben Levin GC/VP Legal Affairs/Secy - [O] | 33.578 | 5.596 | |
|
Scott Bradford Patterson
10% Owner -
|
4.577.605 | 762.934 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Joseph Rubinfeld | 180.000 | ||
| Eric Jay Selter Director - [D] | 54.288 | 9.048 | |
| Marvin R Selter Director - [D] | 253.193 | 42.199 | |
| Simpson Jennifer K. Director - [D] | 25.000 | 25.000 | |
| Stephen Snowdy | 300.000 | ||
| Olivia C Ware | 350.000 | ||
| Wennekamp Richard L. Director - [D] | 116.965 | 19.494 | |
| Douglas Scott Wieland | 150.000 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i LADX / LadRx Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i LADX / LadRx Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-12 | 2022-01-10 | 4 | Snowdy Stephen | CYTR | Stock Appreciation Right | D | 0,64 | 300.000 | 300.000 | |||||
| 2022-01-11 | 2021-12-15 | 4/A | Simpson Jennifer K. | CYTR | Stock Appreciation Right | D | 0,45 | 50.000 | 50.000 | |||||
| 2021-12-17 | 2021-12-15 | 4 | Simpson Jennifer K. | CYTR | Common Stock | D | 25.000 | 25.000 | ||||||
| 2020-08-20 | 2020-08-14 | 4 | Brien Earl W | CYTR | Stock Option (right to buy) | D | 0,26 | -150.000 | 300.000 | |||||
| 2020-08-20 | 2020-08-14 | 4 | Brien Earl W | CYTR | Common Stock, par value $0.001 per share | D | 0,2600 | 150.000 | 39 | 590.247 | ||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0,26 | -3.000.000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock, par value $0.001 per share | D | 0,6700 | -1.164.179 | -780 | 3.668.038 | ||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock, par value $0.001 per share | D | 0,2600 | 3.000.000 | 780 | 4.832.217 | ||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Stock Option (right to buy) | D | 0,26 | -450.000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Common Stock, par value $0.001 per share | D | 0,6700 | -174.627 | -117 | 335.373 | ||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Common Stock, par value $0.001 per share | D | 0,2600 | 450.000 | 117 | 510.000 | ||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0,26 | -700.000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Common Stock, par value $0.001 per share | D | 0,6700 | -271.642 | -182 | 600.785 | ||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Common Stock, par value $0.001 per share | D | 0,2600 | 700.000 | 182 | 872.427 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Brien Earl W | CYTR | Stock option (right to buy) | D | 0,26 | 450.000 | 450.000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 0,26 | 450.000 | 450.000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 0,26 | 350.000 | 350.000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0,26 | 700.000 | 700.000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0,26 | 3.000.000 | 3.000.000 | |||||
| 2018-01-02 | 2017-12-15 | 4 | Kratz Felix | CYTR | Stock Option (right to buy) | D | 1,75 | 25.000 | 25.000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 1,75 | 208.334 | 208.334 | |||||
| 2017-12-19 | 2017-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | CytRx Common Stock | D | 1,7500 | 387.597 | 678 | 387.597 | ||||
| 2017-12-19 | 2017-12-15 | 4 | Brien Earl W | CYTR | Stock option (right to buy) | D | 1,75 | 70.000 | 70.000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 1,75 | 30.000 | 30.000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1,75 | 58.334 | 58.334 | |||||
| 2017-12-19 | 2017-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 1,75 | 30.000 | 30.000 | |||||
| 2017-09-06 | 2017-07-12 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 0,67 | 180.000 | 180.000 | |||||
| 2017-06-20 | 3 | Chawla Shanta M.D. | CYTR | CytRx Common Stock | D | 4.200 | ||||||||
| 2017-06-20 | 3 | Chawla Shanta M.D. | CYTR | CytRx Common Stock | D | 4.200 | ||||||||
| 2016-12-20 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0,43 | 1.250.000 | 1.250.000 | |||||
| 2016-12-20 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0,4300 | 2.325.581 | 1.000 | 2.325.581 | ||||
| 2016-12-19 | 2016-12-15 | 4 | Brien Earl W | CYTR | Stock Option (right to buy) | D | 0,43 | 180.000 | 180.000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | Chawla Anita J | CYTR | Stock Option (right to buy) | D | 0,43 | 180.000 | 180.000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0,43 | 180.000 | 180.000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 0,43 | 180.000 | 180.000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0,43 | 1.250.000 | 1.250.000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 0,43 | 350.000 | 350.000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 0,43 | 150.000 | 150.000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 0,43 | 400.000 | 400.000 | |||||
| 2016-12-09 | 3/A | Brien Earl W | CYTR | CytRx Common Stock | D | 61.484 | ||||||||
| 2016-12-06 | 3 | Brien Earl W | CYTR | CytRx Common Stock | D | 120.000 | ||||||||
| 2016-12-06 | 3 | Brien Earl W | CYTR | CytRx Common Stock | D | 120.000 | ||||||||
| 2016-12-06 | 2016-12-02 | 4 | Brien Earl W | CYTR | Stock options (right to buy) | D | 0,52 | 180.000 | 180.000 | |||||
| 2016-01-14 | 2016-01-11 | 4 | Ware Olivia C | CYTR | Stock option (right to buy) | D | 2,15 | 350.000 | 350.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 2,44 | 180.000 | 180.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | SELTER ERIC JAY | CYTR | Stock Option (right to buy) | D | 2,44 | 180.000 | 180.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Chawla Anita J | CYTR | Stock Option (right to buy) | D | 2,44 | 180.000 | 180.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Cohen Cheryl | CYTR | Stock Option (right to buy) | D | 2,44 | 180.000 | 180.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2,44 | 100.000 | 100.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2,44 | 300.000 | 300.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 2,44 | 500.000 | 500.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 2,44 | 300.000 | 300.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2,44 | 180.000 | 180.000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2,44 | 1.000.000 | 1.000.000 | |||||
| 2015-05-04 | 3 | SELTER ERIC JAY | CYTR | CytRx Common Stock | D | 54.288 | ||||||||
| 2015-05-04 | 3 | SELTER ERIC JAY | CYTR | CytRx Common Stock | D | 54.288 | ||||||||
| 2014-12-17 | 2014-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2,15 | 200.000 | 200.000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option | D | 2,15 | 200.000 | 200.000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2,15 | 200.000 | 200.000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option | D | 2,15 | 400.000 | 400.000 | |||||
| 2014-12-16 | 2014-12-15 | 4/A | IGNARRO LOUIS | CYTR | Stock Option (right to buy | D | 2,15 | 180.000 | 180.000 | |||||
| 2014-12-16 | 2014-12-15 | 4/A | RUBINFELD JOSEPH | CYTR | Stock option (right to buy) | D | 2,15 | 180.000 | 180.000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2,15 | 600.000 | 600.000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2,15 | 180.000 | 180.000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy | D | 2,15 | 180.000 | 180.000 | |||||
| 2014-12-16 | 2015-12-15 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 2,15 | 180.000 | 180.000 | |||||
| 2014-01-28 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100.000 | 161.036 | ||||||
| 2014-01-10 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100.000 | 157.983 | ||||||
| 2014-01-03 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100.000 | 157.706 | ||||||
| 2014-01-03 | 2014-01-01 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 100.000 | 214.286 | ||||||
| 2013-12-12 | 2013-12-10 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 2,39 | 180.000 | 180.000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 2,39 | 180.000 | 180.000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2,39 | 180.000 | 180.000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2,39 | 300.000 | 300.000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 2,39 | 180.000 | 180.000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 2,39 | 500.000 | 500.000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2,39 | -180.000 | 0 | |||||
| 2013-12-12 | 2013-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2,39 | 180.000 | 180.000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,4039 | -334.979 | -805 | 4.577.605 | ||||
| 2013-12-11 | 2013-12-10 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 2,39 | 150.000 | 150.000 | |||||
| 2013-12-11 | 2013-12-10 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2,39 | 925.000 | 925.000 | |||||
| 2013-12-11 | 2013-12-10 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2,39 | 150.000 | 150.000 | |||||
| 2013-12-03 | 2013-12-03 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,3476 | 42.131 | 99 | 4.912.584 | ||||
| 2013-12-03 | 2013-12-02 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,3910 | 77.148 | 184 | 4.870.453 | ||||
| 2013-12-03 | 2013-11-29 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,4813 | 165.700 | 411 | 4.793.305 | ||||
| 2013-11-08 | 2013-11-07 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,0568 | 50.000 | 103 | 4.627.605 | ||||
| 2013-04-03 | 2013-04-01 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,7000 | 4.083 | 11 | 4.577.605 | ||||
| 2013-03-22 | 2013-03-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,6100 | 3.980 | 10 | 4.573.522 | ||||
| 2013-03-20 | 2013-03-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,5704 | 8.420 | 22 | 4.569.542 | ||||
| 2013-03-20 | 2013-03-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,5795 | 24.100 | 62 | 4.561.122 | ||||
| 2013-03-20 | 2013-03-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,5556 | 3.000 | 8 | 4.537.022 | ||||
| 2013-03-14 | 2013-03-13 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,5199 | 360 | 1 | 4.534.022 | ||||
| 2013-03-14 | 2013-03-11 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,6680 | 55.000 | 147 | 4.533.662 | ||||
| 2013-03-12 | 2013-03-08 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2,46 | 74.176 | 74.176 | |||||
| 2013-01-07 | 2012-12-31 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100.000 | 114.286 | ||||||
| 2013-01-02 | 2012-12-31 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 100.000 | 200.000 | ||||||
| 2012-12-11 | 2012-12-10 | 4/A | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | KRIEGSMAN STEVEN A | 4wa@gwgz | Stock Option (right to buy) | D | 1,83 | 500.000 | 500.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Wieland Douglas Scott | CYTR | Stock Option(right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 1,83 | -100.000 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 1,83 | 30.000 | 30.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 1,83 | 100.000 | 100.000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8,05 | -7.142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2,80 | -7.142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5,04 | -7.142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5,46 | -7.142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 7,77 | -3.572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 3,99 | -3.572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 23,31 | -3.572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5,88 | -2.142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8,33 | -714 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 16,45 | -1.428 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8,40 | -1.428 | 0 | |||||
| 2012-10-23 | 2012-10-22 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,5072 | 115.000 | 288 | 4.478.662 | ||||
| 2012-10-23 | 2012-10-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,5129 | 65.000 | 163 | 4.363.662 | ||||
| 2012-10-18 | 2012-10-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,5000 | 1.200.000 | 3.000 | 4.298.662 | ||||
| 2012-06-28 | 2012-06-28 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4,9020 | 16.000 | 78 | 3.098.662 | ||||
| 2012-06-28 | 2012-06-27 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5,2316 | 15.824 | 83 | 3.082.662 | ||||
| 2012-06-28 | 2012-06-26 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5,3175 | 13.000 | 69 | 3.066.838 | ||||
| 2012-06-25 | 2012-06-25 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5,1634 | 17.835 | 92 | 3.053.838 | ||||
| 2012-06-25 | 2012-06-22 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4,7411 | 5.334 | 25 | 3.036.003 | ||||
| 2012-06-25 | 2012-06-21 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4,6109 | 4.293 | 20 | 3.030.669 | ||||
| 2012-06-20 | 2012-06-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4,6475 | 7.283 | 34 | 3.026.376 | ||||
| 2012-06-20 | 2012-06-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4,4796 | 9.210 | 41 | 3.019.093 | ||||
| 2012-06-20 | 2012-06-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4,2470 | 4.621 | 20 | 3.009.883 | ||||
| 2012-06-18 | 2012-06-15 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8927 | 3.558 | 14 | 3.005.262 | ||||
| 2012-06-18 | 2012-06-14 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8323 | 10.976 | 42 | 3.001.704 | ||||
| 2012-06-14 | 2012-06-13 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8817 | 14.176 | 55 | 2.990.728 | ||||
| 2012-06-14 | 2012-06-12 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8015 | 5.594 | 21 | 2.976.552 | ||||
| 2012-06-12 | 2012-06-11 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8042 | 23.399 | 89 | 2.970.958 | ||||
| 2012-06-12 | 2012-06-08 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8010 | 20.933 | 80 | 2.947.559 | ||||
| 2012-06-07 | 2012-06-07 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8457 | 53.635 | 206 | 2.926.626 | ||||
| 2012-06-07 | 2012-06-06 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,9659 | 24.894 | 99 | 2.872.991 | ||||
| 2012-06-07 | 2012-06-05 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8513 | 66.704 | 257 | 2.848.097 | ||||
| 2012-06-04 | 2012-06-04 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,5254 | 221.000 | 779 | 2.863.292 | ||||
| 2012-06-04 | 2012-06-01 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,7364 | 86.696 | 324 | 2.642.292 | ||||
| 2012-06-04 | 2012-05-31 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3,8324 | 190.200 | 729 | 2.555.596 | ||||
| 2012-05-31 | 3 | Patterson Scott Bradford By Spouse | CYTR | CYTR Common Stock, $0.01 par value per share | I | 81.899 | ||||||||
| 2012-05-31 | 3 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.283.497 | ||||||||
| 2012-05-15 | 2012-05-14 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0,40 | 50.000 | 50.000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 0,40 | 50.000 | 50.000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 0,40 | 50.000 | 50.000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 0,40 | 50.000 | 50.000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 0,40 | 50.000 | 50.000 | |||||
| 2012-02-24 | 2012-02-23 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0,3265 | 105.517 | 34 | 4.179.776 | ||||
| 2012-02-24 | 2012-02-22 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0,3093 | 53.159 | 16 | 4.074.259 | ||||
| 2012-02-24 | 2012-02-23 | 4 | Levin Ben | CYTR | Common Stock | D | 0,3265 | 22.329 | 7 | 33.578 | ||||
| 2012-02-24 | 2012-02-22 | 4 | Levin Ben | CYTR | Common Stock | D | 0,3093 | 11.249 | 3 | 11.249 | ||||
| 2012-02-24 | 2012-02-22 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 0,2875 | 100.000 | 29 | 100.000 | ||||
| 2012-02-24 | 2012-02-23 | 4 | Wennekamp Richard L. | CYTR | Common Stock | D | 0,3265 | 74.455 | 24 | 116.965 | ||||
| 2012-02-24 | 2012-02-22 | 4 | Wennekamp Richard L. | CYTR | Common Stock | D | 0,3093 | 37.510 | 12 | 42.510 | ||||
| 2012-02-24 | 2012-02-22 | 4 | SELTER MARVIN R | CYTR | Common Stock | D | 0,3120 | 100.000 | 31 | 253.193 | ||||
| 2012-02-24 | 2012-02-23 | 4 | CALOZ JOHN Y | CYTR | Common Stock | D | 0,3265 | 21.141 | 7 | 31.792 | ||||
| 2012-02-24 | 2012-02-22 | 4 | CALOZ JOHN Y | CYTR | Common Stock | D | 0,3093 | 10.651 | 3 | 10.651 | ||||
| 2012-02-24 | 2012-02-23 | 4 | LINK MAX | CYTR | Common Stock | D | 0,3265 | 136.540 | 45 | 260.305 | ||||
| 2012-02-24 | 2012-02-22 | 4 | LINK MAX | CYTR | Common Stock | D | 0,3093 | 68.789 | 21 | 123.765 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
